These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22610988)

  • 1. Could Pentoxifylline (PTX) be a promising agent to reduce the systemic inflammation in hemodialysis patients?
    Ji Q; Liu J; Gong D
    Nephrol Dial Transplant; 2012 Jul; 27(7):2997; author reply 2997-8. PubMed ID: 22610988
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
    González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
    Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients.
    Meuwese CL; Snaedal S; Halbesma N; Stenvinkel P; Dekker FW; Qureshi AR; Barany P; Heimburger O; Lindholm B; Krediet RT; Boeschoten EW; Carrero JJ
    Nephrol Dial Transplant; 2011 Apr; 26(4):1313-8. PubMed ID: 20846939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Plasma Cyclophillin A in Hemodialysis and Peritoneal Dialysis Patients: a Novel Link to Systemic Inflammation.
    Jin K; Vaziri ND
    Iran J Kidney Dis; 2017 Jan; 11(1):44-49. PubMed ID: 28174352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous pentoxifylline in inflammatory response in patients undergoing nephrolithotomy.
    Izadpanah F; Mojtahedzadeh M; Kazem Aghamir SM; Atharikia D; Dashti S; Abbasi A
    J Endourol; 2009 Feb; 23(2):323-8. PubMed ID: 19220089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Clinical Trial of the Effect of Pentoxifylline on C-Reactive Protein Level and Dialysis Adequacy in End-stage Renal Disease Patients on Maintenance Hemodialysis.
    Soltani P; Ketabi Moghaddam P; Haghverdi F; Cheraghi A
    Iran J Kidney Dis; 2016 Sep; 10(5):299-303. PubMed ID: 27721228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis.
    Selim K; Hüseyin C; Ibrahim KH; Hasan BU; Kazim U; Hüseyin K
    Med J Malaysia; 2004 Aug; 59(3):391-4. PubMed ID: 15727386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased SOCS expression in peripheral blood mononuclear cells of end stage renal disease patients is related to inflammation and dialysis modality.
    Rastmanesh MM; Braam B; Joles JA; Boer P; Bluyssen HA
    Eur J Pharmacol; 2009 Jan; 602(1):163-7. PubMed ID: 19041303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease.
    Barreto DV; Barreto FC; Liabeuf S; Temmar M; Lemke HD; Tribouilloy C; Choukroun G; Vanholder R; Massy ZA;
    Kidney Int; 2010 Mar; 77(6):550-6. PubMed ID: 20016471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intima-media thickness is associated with non-traditional risk factors and ischemic heart disease in hemodialysis patients.
    Alvarez-Aguilar C; Lara-Romero D; Piñón-Escobedo J; Gómez-García A; Alvarez-Paredes AR
    Ther Apher Dial; 2012 Feb; 16(1):104-6. PubMed ID: 22248204
    [No Abstract]   [Full Text] [Related]  

  • 12. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
    Perunicic-Pekovic G; Pljesa S; Rasic-Milutinovic Z; Stankovic S; Ilic M; Maletic R
    Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microinflammation versus inflammation in chronic renal failure patients.
    Tsirpanlis G; Chatzipanagiotou S; Nicolaou C
    Kidney Int; 2004 Nov; 66(5):2093-4. PubMed ID: 15496193
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytokines, adipocytokines and inflammatory markers in patients on continuous ambulatory peritoneal dialysis and hemodialysis.
    Oncel M; Akbulut S; Toka Ozer T; Kiyici A; Keles M; Baltaci B; Turk S
    Ren Fail; 2016 Aug; 38(7):1071-5. PubMed ID: 27267129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is systemic inflammation of hemodialysis patients improved with the use of enalapril? Results of a randomized, double-blinded, placebo-controlled clinical trial.
    Ordaz-Medina SM; González-Plascencia J; Martín del Campo F; Rojas-Campos E; Montañez-Fernández JL; Espinoza-Gómez F; Cueto-Manzano AM
    ASAIO J; 2010; 56(1):37-41. PubMed ID: 20051840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of oxidative stress and cellular inflammation in patients with diabetic nephropathy and non-diabetic nephropathy being administered hemodialysis treatment due to chronic renal failure.
    Avci E; Cakir E; Cevher SC; Yaman H; Agilli M; Bilgi C
    Ren Fail; 2014 Jun; 36(5):767-73. PubMed ID: 24579657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients.
    Park CW; Shin YS; Kim CM; Lee SY; Yu SE; Kim SY; Choi EJ; Chang YS; Bang BK
    Am J Kidney Dis; 2002 Dec; 40(6):1230-9. PubMed ID: 12460042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of dialysis type on biomarkers for cardiovascular diseases.
    Sahinarslan A; Güz G; Mutluay R; Okyay K; Demirtaş C; Paşaoğlu H; Yalçın R
    Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter?
    Yigit IP; Celiker H; Dogukan A; Ilhan N; Gurel A; Ulu R; Aygen B
    Ren Fail; 2015 Feb; 37(1):77-82. PubMed ID: 25347233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of statins on chronic inflammation and nutrition status in renal dialysis patients: a systematic review and meta-analysis.
    Deng J; Wu Q; Liao Y; Huo D; Yang Z
    Nephrology (Carlton); 2012 Aug; 17(6):545-51. PubMed ID: 22429568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.